Amgen: Biotech Cash Flows, Blockbuster Biologics, and Pipeline Risk
Amgen Inc. is one of the world's largest independent biotechnology companies. This explainer covers blockbuster biologics, biosimilar competition, the Horizon Therapeutics acquisition, obesity pipeline (MariTide), capital allocation, and key risks.
May 26, 2026
